Market Research Logo

International Stem Cell Corporation - Product Pipeline Review - 2015

International Stem Cell Corporation - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘International Stem Cell Corporation - Product Pipeline Review - 2015’, provides an overview of the International Stem Cell Corporation’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of International Stem Cell Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of International Stem Cell Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of International Stem Cell Corporation’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the International Stem Cell Corporation’s pipeline products
Reasons to buy
  • Evaluate International Stem Cell Corporation’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of International Stem Cell Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the International Stem Cell Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of International Stem Cell Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of International Stem Cell Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of International Stem Cell Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


International Stem Cell Corporation Snapshot
International Stem Cell Corporation Overview
Key Information
Key Facts
International Stem Cell Corporation - Research and Development Overview
Key Therapeutic Areas
International Stem Cell Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
International Stem Cell Corporation - Pipeline Products Glance
International Stem Cell Corporation - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
International Stem Cell Corporation - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
International Stem Cell Corporation - Drug Profiles
ISC-hpNSC
Product Description
Mechanism of Action
R&D Progress
CytoCor
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Age Related Macular Degeneration and Retinitis Pigmentosa
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Alpha-Antitrypsin Deficiency and Crigler-Najjar Syndrome
Product Description
Mechanism of Action
R&D Progress
International Stem Cell Corporation - Pipeline Analysis
International Stem Cell Corporation - Pipeline Products by Molecule Type
International Stem Cell Corporation - Recent Pipeline Updates
International Stem Cell Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
International Stem Cell Corporation, Key Information
International Stem Cell Corporation, Key Facts
International Stem Cell Corporation - Pipeline by Indication, 2015
International Stem Cell Corporation - Pipeline by Stage of Development, 2015
International Stem Cell Corporation - Monotherapy Products in Pipeline, 2015
International Stem Cell Corporation - Phase I, 2015
International Stem Cell Corporation - Preclinical, 2015
International Stem Cell Corporation - Pipeline by Molecule Type, 2015
International Stem Cell Corporation - Recent Pipeline Updates, 2015
International Stem Cell Corporation, Other Locations
International Stem Cell Corporation, Subsidiaries
List of Figures
International Stem Cell Corporation - Pipeline by Top 10 Indication, 2015
International Stem Cell Corporation - Pipeline by Stage of Development, 2015
International Stem Cell Corporation - Monotherapy Products in Pipeline, 2015
International Stem Cell Corporation - Pipeline by Top 10 Molecule Type, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report